20% Off for 5+ Items
Starting now, ending on Dec. 31st, enjoy 20% discount on 5 or more items storewide.
Up to 10 - color IHC Detection Kits
High-plex targeted protein panels,Complete assay solution, automation ready, with ability to customize
New Products
Comprehensive assay kits for drug screening
Featured Products
-
UA-Glo® cAMP Reagent
Shop Now -
UA-Glo® BRET Ligand 618
Shop Now -
-
UA-Glo® BRET Detection System
Shop Now -
-
-
-
-
-
UA-Glo® AMP Assay Kit
Shop Now -
UA-Glo® Kinase ADP Max Assay Kit
Shop Now -
Promotion 1:
20% off for 5+ items
Enjoy 20% discount on 5 or more items storewide including OneStep ELISA Kits, mIHC Kits, IHC antibodies, Organoid Culture Kits, PTMs antibodies and so on.
Promo Period: 1 January 2026 to 30 April 2026
Promotion 2:
Buy Antibodies, Get Free Items!
- Buy IHC primary antibodies and get a free secondary antibody (same size, pecies selectable).
- Buy IVD-paired antibodies and receive 25 μg of therapeutic target free.
- Buy PTM antibodies and get a free PTM auxiliary reagent.
March 10 to April 30, 2026
Promotion 3:
20% off on label/reference antibodies
High specificity and affinity
High sensitivity
High stability
Low batch-to-batch variation
Multiple application validations
Promo Period: 1 January 2026 to 30 April 2026
Promotion 4:
Anti-Rabbit and Mouse HRP-DAB IHC detection kit (2-step), S0C2011
Promotion price: $120
Biotin-free polymerization technology eliminates endogenous biotin background
Polymer HRP has higher sensitivity and stability
Promo Period: 1 January 2026 to 30 April 2026
About Us
AntBio - Life Science Research Tools
AntBio is a biotechnology group company dedicated to serving life sciences, aiming to help scientists accelerate research and improve work efficiency. AntBio provides comprehensive and high-quality reagent tools for basic research, drug development, and diagnosis, including research grade antibodies, proteins, biochemical reagents, and assay kits. These research tools are widely used in different segments of life science research. The group company currently consists of three brands, Absin, Starter-Bio and UA-Bio.
50k
Happy Clients
100k
Products
70+
Doctor/Expert
20+
Life Science Experience
ARTICLES
Latest News
c-Met Receptor Antibodies: ...
Discover c-Met/HGF RTK structural features, widespread overexpression across solid tumors and core preclinical research challenges including therapeutic resistance and heterogeneous MET amplification. Compare anti-c-Met monoclonal antibodies versus small-molecule TKIs, covering...
c-Met Receptor Antibodies: ...
Discover c-Met/HGF RTK structural features, widespread overexpression across solid tumors and core preclinical research challenges including therapeutic resistance and heterogeneous...
View Details
Pan-Cytokeratin (CK-Pan) Antibodies: ...
Molecular Basis That Establishes CK-Pan Antibodies as Essential Cytoskeleton Probes Cytokeratins form a diverse subset of intermediate filament proteins that exclusively construct the core cytoskeletal scaffold within epithelial cell populations.Pan-cytokeratin...
Pan-Cytokeratin (CK-Pan) Antibodies: ...
Molecular Basis That Establishes CK-Pan Antibodies as Essential Cytoskeleton Probes Cytokeratins form a diverse subset of intermediate filament proteins that...
View Details
Anti-CD146 Antibodies for Mechanistic...
Explore tissue-specific CD146 (MCAM) expression in adipose remodeling, covering ANGPTL2-CREB white adipogenic signaling and galectin-1-mediated suppression of brown fat UCP1 thermogenesis. CD146 drives lipid storage, adipocyte hypertrophy and low-grade inflammation...
Anti-CD146 Antibodies for Mechanistic...
Explore tissue-specific CD146 (MCAM) expression in adipose remodeling, covering ANGPTL2-CREB white adipogenic signaling and galectin-1-mediated suppression of brown fat UCP1...
View Details
Small-Molecule PITPNM3 Inhibitors: Me...
Address key experimental hurdles in tumor metastasis research focusing on PITPNM3, a plasma membrane receptor activated by TAM-secreted CCL18 to drive PTK2B/EMT invasive signaling across breast, liver and pancreatic cancer....
Small-Molecule PITPNM3 Inhibitors: Me...
Address key experimental hurdles in tumor metastasis research focusing on PITPNM3, a plasma membrane receptor activated by TAM-secreted CCL18 to...
View Details